Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 141

1.

Evaluation of Outcome and Tolerability of Combination Chemotherapy with Capecitabine and Oxaliplatin as First Line Therapy in Advanced Gastric Cancer.

Mashhadi MA, Sepehri Z, Bakhshipour AR, Zivari A, Danesh HA, Metanat HA, Karimkoshteh A, Hashemi SM, Rahimi H, Kiani Z.

Int J Hematol Oncol Stem Cell Res. 2016 Oct 1;10(4):212-216.

2.
3.

Non-classic EGFR mutations in a cohort of Dutch EGFR-mutated NSCLC patients and outcomes following EGFR-TKI treatment.

Kuiper JL, Hashemi SM, Thunnissen E, Snijders PJ, Grünberg K, Bloemena E, Sie D, Postmus PE, Heideman DA, Smit EF.

Br J Cancer. 2016 Dec 6;115(12):1504-1512. doi: 10.1038/bjc.2016.372.

PMID:
27875527
4.

In Vitro Activities of Novel Azole Compounds ATTAF-1 and ATTAF-2 against Fluconazole-Susceptible and -Resistant Isolates of Candida Species.

Fakhim H, Emami S, Vaezi A, Hashemi SM, Faeli L, Diba K, Dannaoui E, Badali H.

Antimicrob Agents Chemother. 2016 Dec 27;61(1). pii: e01106-16. doi: 10.1128/AAC.01106-16.

PMID:
27795371
5.

The Relationship Between Risk Factors and Survival in Adult Acute Lymphoblastic Leukemia.

Allahyari A, Hashemi SM, Nazemian F, Karimi M, Kazemi MR, Sadeghi M.

Iran J Cancer Prev. 2016 Aug 10;9(4):e5045.

6.

Introducing a New Experimental Islet Transplantation Model using Biomimetic Hydrogel and a Simple High Yield Islet Isolation Technique.

Mohammadi Ayenehdeh J, Niknam B, Hashemi SM, Rahavi H, Rezaei N, Soleimani M, Tajik N.

Iran Biomed J. 2016 Oct 18. pii: Pii-IBJ-A-10-2009-1. [Epub ahead of print]

PMID:
27752182
7.

FEN1 -69G>A and +4150G>T polymorphisms and breast cancer risk.

Rezaei M, Hashemi M, Sanaei S, Mashhadi MA, Hashemi SM, Bahari G, Taheri M.

Biomed Rep. 2016 Oct;5(4):455-460.

8.

Leishmaniasis as a Neglected Cause of Isolated Lymphadenopathy: A Case Report.

Shorafa E, Poladfar G, Adelian R, Shariat M, Minaee MR, Hashemi SM, Tazang M.

Iran J Public Health. 2016 Jul;45(7):946-8.

9.

Intratympanic dexamethasone injection vs methylprednisolone for the treatment of refractory sudden sensorineural hearing loss.

Berjis N, Soheilipour S, Musavi A, Hashemi SM.

Adv Biomed Res. 2016 Jun 20;5:111. doi: 10.4103/2277-9175.184277.

10.

Evaluation of the pri-miR-34b/c rs4938723 polymorphism and its association with breast cancer risk.

Sanaei S, Hashemi M, Rezaei M, Hashemi SM, Bahari G, Ghavami S.

Biomed Rep. 2016 Jul;5(1):125-129.

11.

Comparison of TGF-β1 and NO production by mesenchymal stem cells isolated from murine lung and adipose tissues.

Hosseinpur Z, Hashemi SM, Salehi E, Ghazanfari T.

Immunopharmacol Immunotoxicol. 2016 Jun;38(3):214-20. doi: 10.3109/08923973.2016.1168434.

PMID:
27097976
12.

miR-608 rs4919510 C>G polymorphism decreased the risk of breast cancer in an Iranian subpopulation.

Hashemi M, Sanaei S, Rezaei M, Bahari G, Hashemi SM, Mashhadi MA, Taheri M, Ghavami S.

Exp Oncol. 2016 Mar;38(1):57-9.

PMID:
27031722
13.

A case of choriocarcinoma with concurrent rare presentations: Spontaneous uterine rupture and extensive thoracic spine metastases.

Hashemi SM, Derakhshandi H, Fazeli SA, Sanei Sistani S, Amirifard H.

J Obstet Gynaecol. 2016 Jul;36(5):679-80. doi: 10.3109/01443615.2015.1127904. No abstract available.

PMID:
27012373
14.

Sporadic colonic polyposis and adenocarcinoma associated with lymphoblastic and large B-cell lymphoma in a young male patient: A case report.

Hashemi SM, Fazeli SA, Arabpour-Dahouei F, Davarian A, Golabchifard R.

Mol Clin Oncol. 2016 Mar;4(3):450-452.

15.

Rituximab for refractory subcutaneous Sweet's syndrome in chronic lymphocytic leukemia: A case report.

Hashemi SM, Fazeli SA, Vahedi A, Golabchifard R.

Mol Clin Oncol. 2016 Mar;4(3):436-440.

16.
17.

Endothelial dysfunction in patients with sudden sensorineural hearing loss.

Berjis N, Moeinimehr M, Hashemi SM, Hashemi SM, Bakhtiari EK, Nasiri S.

Adv Biomed Res. 2016 Jan 27;5:5. doi: 10.4103/2277-9175.174978.

18.

In vivo immunomodulatory effects of adipose-derived mesenchymal stem cells conditioned medium in experimental autoimmune encephalomyelitis.

Yousefi F, Ebtekar M, Soudi S, Soleimani M, Hashemi SM.

Immunol Lett. 2016 Apr;172:94-105. doi: 10.1016/j.imlet.2016.02.016.

PMID:
26930038
19.

Hollow Mesoporous Plasmonic Nanoshells for Enhanced Solar Vapor Generation.

Zielinski MS, Choi JW, La Grange T, Modestino M, Hashemi SM, Pu Y, Birkhold S, Hubbell JA, Psaltis D.

Nano Lett. 2016 Apr 13;16(4):2159-67. doi: 10.1021/acs.nanolett.5b03901.

PMID:
26918518
20.

Validation of the prediction model for inhibitor development in PUPs with severe haemophilia A.

Hashemi SM, Fischer K, Moons KG, van den Berg HM; PedNet Study group..

Haemophilia. 2016 Feb 8. doi: 10.1111/hae.12895. [Epub ahead of print] No abstract available.

PMID:
26856685
Items per page

Supplemental Content

Loading ...
Support Center